Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
Takahiro TakaseAkinobu NakamuraChiho YamamotoHiroshi NomotoAika MiyaMidori DannouraKyu Yong ChoYoshio KuriharaNaoki MandaShin AokiTatsuya AtsumiHideaki MiyoshiPublished in: Journal of diabetes investigation (2018)
Weekly administration of dulaglutide was superior to liraglutide with regard to treatment satisfaction in patients with type 2 diabetes, in the absence of any negative effect on glycemic control.